StockWatch
·

DANLAW TECHNOLOGIES INDIA LTD.-$ Q2 FY27 Results

DANLAWQ2 FY27 Results
Filing
Result:Very Good· Market: Up#Broad based#Margin expansion
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue86.6617.6%32.1%
Total Income86.9517.6%32.1%
Expenditure76.6916.3%31.3%
PBT10.2629.1%38.9%
Net Profit7.8331.9%42.3%
OPM15.61%2.19pp0.98pp
NPM9.00%0.97pp0.65pp
EPS16.0731.9%42.3%
View full financials

PAT +42.3% YoY on revenue +32.1% YoY with expanding operating leverage (NPM 9.0% vs 8.35%, OPM 15.6% vs 14.6%) and no one-offs, a clean standout for an Industrials name — capped short of the very top given the small base and rising receivables to watch.

Q2 FY-2027 RESULTS · DANLAW

Danlaw Technologies Q2 FY27: standalone PAT +42% YoY to ₹7.83 Cr, margins expand

PAT +42.3% YoY · revenue +32.1% · margins expanding

13 Nov 2026 · 3 min read
Revenue

₹86.66 Cr

+32.1% YoY

PAT (standalone)

₹7.83 Cr

+42.3% YoY

Net margin

9.01%

+0.7pp YoY

EPS

₹16.07

Danlaw Technologies' standalone PAT rose 42.3% YoY to ₹7.83 Cr on revenue of ₹86.66 Cr, up 32.1% YoY — profit growing faster than the topline for the second straight quarter. Sequentially, revenue was up 17.6% QoQ and PAT up 31.9% QoQ versus Q1 FY27 (₹73.72 Cr revenue, ₹5.93 Cr PAT), but with no seasonal retail/consumer pattern at play here, the YoY read carries the verdict. There is no analyst coverage of the stock (zero estimates tracked for this name) and no prior management guidance on record, so vsStreet and vsGuidance cannot be benchmarked this quarter — a gap specific to this micro-cap name rather than a miss on our part.

The scoreboard

Q2 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹86.66 Cr+17.6%+32.1%
Expenses₹76.69 Cr+16.3%+31.3%
PAT₹7.83 Cr+31.9%+42.3%
Net margin9.01%+1pp+0.7pp
EPS₹16.07+31.9%+42.3%

The growth is margin-accretive rather than volume-led alone: net margin expanded to 9.03% from 8.35% a year ago and 8.03% last quarter, while operating margin (EBITDA/revenue) rose to ~15.6% versus 14.63% YoY and 13.42% QoQ, even as cost of materials consumed held near 64% of revenue. Employee costs grew only marginally (₹13.87 Cr vs ₹12.71 Cr YoY) against the much sharper revenue increase, suggesting operating leverage rather than a one-off cost benefit — confirmed by the clean limited-review report with no qualifications and no exceptional items on either side of the YoY comparison. H1 FY27 revenue of ₹160.38 Cr (+33.3% YoY) and PAT of ₹13.76 Cr (+53.4% YoY) show the trend held across both quarters of the half, not just this one print. Trade receivables rose to ₹61.06 Cr from ₹55.82 Cr at FY26-end, a working-capital build worth tracking as revenue scales further.

₹
1,104.971,303.961,502.951,701.941,900.931,464.308-1009-0109-2410-1911-1111-13Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹1,464.3, up 1% over the past month of trading.

₹ Cr
03.567.1210.683.47Q1 FY26rev ₹55 Cr5.5Q2 FY26rev ₹66 Cr4.48Q3 FY26rev ₹62 Cr9.54Q4 FY26rev ₹80 Cr5.93Q1 FY27rev ₹74 Cr7.83Q2 FY27rev ₹87 Cr
Quarterly standalone PAT, ₹ Crore

For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.

Beyond the headline

What the summary numbers don't show

EPS ₹16.07 vs ₹11.29 YoY and ₹12.18 QoQ

Unaudited results approved by Board Nov 13, 2026 — limited review report unqualified

  • W1

    Whether OPM (~15.6% this quarter) holds above the 13-15% band seen in the prior two quarters as cost of materials stays near 64% of revenue

  • W2

    Trade receivables build to ₹61.06 Cr (Sept 30) from ₹55.82 Cr (Mar 31) — working-capital trend to watch as revenue scales

  • W3

    H2 FY27 pace needed to clear FY26's full-year revenue of ₹261.96 Cr, given H1 FY27 already at ₹160.38 Cr

Filing carries only one P&L statement (no separate consolidated section); treated as standalone, consistent with comparison context. No exceptional items in the current or year-ago quarter. Figures converted from ₹ Lakh (source) to ₹ Crore.

Informational and educational content only. Not investment advice.